Abstract: Personal qualified dividend income (QDI) is calculated for one or more investors for mutual fund dividend distributions made to accounts of the investors from one or more mutual funds. A first database stores account transaction history data of the investors for each of the mutual funds. A second database stores dividend distribution information for each of the mutual funds and information indicating what percentage of dividend distributions of each of the mutual funds are QDI. A QDI calculation engine receives and processes the account transaction history data, the dividend distribution information, and the percentage of mutual fund dividend distributions that are QDI from the first and second databases to automatically determine the personal QDI for a selected time frame for one or more of the investors. The account transaction history data is used to provide transaction data for a specific investor and to determine whether holding period requirements are met for a specific investor.

Abstract: The invention includes a chimeric virus for use in a vaccine preparation having a genome comprising nucleic acid sequences encoding at least one structural protein from one flavivirus and nucleic acid sequences encoding nonstructural protein from another flavivirus. The genome preferably includes mutations within the viral genome that reduce virus virulence and in a particularly preferred embodiment these vaccines are directed to flaviviruses such as dengue virus, tick-borne encephalitis virus and Japanese encephalitis virus. The invention also includes a baculovirus having a recombinant dengue cDNA sequence which encodes: (1) dengue virus capsid protein, pre-matrix protein, envelope glycoprotein and NS1 and NS2a nonstructural proteins or (2) dengue envelope glycoprotein or (3) dengue non-structural proteins NS1 and NS2a.

Abstract: A method for locking elements of a hierarchical data structure to allow multiple users at various distributed clients to simultaneously edit unlocked portions of the data structure, and systems for same are disclosed. The method includes checking for permission, setting and releasing various kind of locks. The structured authoring system of the invention may be distributed and collaborative. The process of checking for permission to set a lock is unique for each type of lock.

Abstract: The invention includes a chimeric virus for use in a vaccine preparation having a genome comprising nucleic acid sequences encoding at least one structural protein from one flavivirus and nucleic acid sequences encoding nonstructural protein from another flavivirus. The genome preferably includes mutations within the viral genome that reduce virus virulence and in a particularly preferred embodiment these vaccines are directed to flaviviruses such as dengue virus, tick-borne encephalitis virus and Japanese encephalitis virus. The invention also includes a baculovirus having a recombinant dengue cDNA sequence which encodes: (1) dengue virus capsid protein, pre-matrix protein, envelope glycoprotein and NS1 and NS2a nonstructural proteins or (2) dengue envelope glycoprotein or (3) dengue non-structural proteins NS1 and NS2a.

Abstract: The present invention relates to a device for determining the shape of the wave surface reflected by a substantially plane component (P), which includes a support (S) for the component (P), an interferometer (I), means for moving the support (S), and a control unit which determines, from the measurements by the interferometer (I), the shape of said wave surface.According to the invention, the device additionally includes a swivelling mirror (M1), which directs the measurement beam (FM) of the interferometer (I) orthogonally onto a surface (2) of the component (P), and an optical sensor (CO), which determines the position of the image of a light point (PO) of the measurement beam (FM), the orientation of the mirror (M1) being controlled in such a way as to bring the light point (PO) back to a reference position automatically.

Abstract: The present invention relates to a device for determining the shape of the wave surface transmitted by a substantially parallel-faced transparent component (P), which includes a support (S) for the component (P), an interferometer (I), means for moving the support (S), and a control unit which determines, from the measurements by the interferometer (I), the shape of said wave surface. According to the invention, the support (S) is made in such a way as to let the light beam (FM) emitted by the interferometer (I) and transmitted by the component (P), which is transparent, pass through it, and said device includes a swivelling mirror (M1) arranged approximately orthogonally to the beam (FM) transmitted by the component and oriented in such a way as to send said beam (FM) back in the emission direction (D1).

Abstract: The present invention relates to C-terminally truncated flavivirus envelope proteins 80-81% in size which are more immunogenic than their counterpart full-length proteins. The present invention further relates to recombinant viruses which encode the truncated protein and to host cells infected therewith. Host cells express the truncated protein on their outer membrane and secrete it into the medium. The present invention further relates to vaccines for use against flavivirus infection. The vaccines include either a recombinant vaccinia virus expressing the truncated envelope protein of the present invention, and the truncated envelope protein produced by a recombinant baculovinis.